Pneumocystis cariini Pneumonia Management

Medical Advocates
Pneumocystis jirovecii (carinii) Pneumonia

Clinical Management

General Management Challenges
HIV-Associated Pneumonia
Non-HIV-Associated Pneumonia
Prevention/Treatment Guidelines
Drugs

P. Pneumonia Main Page

Main New/Newsworthy

Home Page

Last Update: January 02, 2011
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

General Management Challenges

Journal Papers, Abstracts, and Commentaries

Update on the diagnosis and treatment of Pneumocystis pneumonia.
Carmona EM, Limper AH.T
her Adv Respir Dis. 2010 Aug 24.
Abstract

Pneumocystis infection in humans: diagnosis and treatment.
Calderón EJ, Gutiérrez-Rivero S, Durand-Joly I, Dei-Cas E.
Expert Rev Anti Infect Ther. 2010 Jun;8(6):683-70
Abstract

A Survey of Rheumatologists' Practice for Prescribing Pneumocystis Prophylaxis.
Cettomai D, Gelber AC, Christopher-Stine L.
J Rheumatol. 2010 Mar
Abstract

Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment.
Kovacs JA, Masur H.
JAMA. 2009 Jun 24;301(24):2578-85
Abstract

Pneumocystis pneumonia: current concepts in pathogenesis, diagnosis, and treatment.
Krajicek BJ, Thomas CF Jr, Limper AH.
Clin Chest Med. 2009 Jun;30(2):265-78,
Abstract

Acute respiratory failure due to Pneumocystis pneumonia: outcome and prognostic factors.
Boonsarngsuk V, Sirilak S, Kiatboonsri S.
Int J Infect Dis. 2008 Jun 21
Abstract

FULL TEXT PDF ARTICLE
Clinical and radiological features of pneumocystis pneumonia in patients with rheumatoid arthritis,
in comparison with methotrexate pneumonitis and pneumocystis pneumonia in acquired
immunodeficiency syndrome: a multicenter study.
Tokuda H, Sakai F, Yamada H, et al
Intern Med. 2008;47(10):915-23.
Paper

Critical care management and outcome of severe Pneumocystis pneumonia in patients
with and without HIV infection.
Monnet X, Vidal-Petiot E, Osman D, et al
Crit Care. 2008 Feb 27;12(1):R28
Abstract

HIV-Associated Pneumocystis Pneumonia

Journal Papers, Abstracts, and Commentaries

Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis
jirovecii pneumonia: a tri-centre cohort study.
Helweg-Larsen J, Benfield T, Atzori C, Miller RF.|
J Antimicrob Chemother. 2009 Dec;64(6):1282-90
Abstract

Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis
jirovecii pneumonia: a tri-centre cohort study.
Helweg-Larsen J, Benfield T, Atzori C, Miller RF.
J Antimicrob Chemother. 2009 Dec;64(6):1282-90
Abstract

Pneumocystis jirovecii pneumonia in patients with and without human immunodeficiency
virus infection.
Su YS, Lu JJ, Perng CL, Chang FY.
J Microbiol Immunol Infect. 2008 Dec;41(6):478-82.
Abstract

Second-Line Salvage Treatment of AIDS-Associated Pneumocystis jirovecii Pneumonia:
A Case Series and Systematic Review.
Benfield T, Atzori C, Miller RF, Helweg-Larsen J.
J Acquir Immune Defic Syndr. 2008 Mar 20
Abstract

Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected
patients: 1985-2006.
Walzer PD, Evans HE, Copas AJ, et al
Clin Infect Dis. 2008 Feb 15;46(4):634-6.
Abstract

Recurrence of Pneumocystis carinii pneumonia in an HIV-infected patient: apparent
selective immune reconstitution after initiation of antiretroviral therapy.
Crothers K, Huang L.
HIV Med. 2003 Oct;4(4):346-349.
Abstract

Assessment of immune reconstitution to Pneumocystis carinii in HIV-1 patients under
different highly active antiretroviral therapy regimens.
Atzori C, Clerici M, Trabattoni , et al.
J Antimicrob Chemother. 2003 Jul 1
Abstract

Discontinuation of secondary prophylaxis for Pneumocystis carinii pneumonia in human
immunodeficiency virus-infected patients: a randomized trial by the CIOP Study Group.
Mussini C, Pezzotti P, Antinori A, et al
Clin Infect Dis 2003 Mar 1;36(5):645-51
Abstract

Improved survival with highly active antiretroviral therapy in HIV-infected patients with
severe Pneumocystis carinii pneumonia.
Morris A, Wachter RM, Luce J, et al.
AIDS 2003 Jan 3;17(1):73-80
Abstract

Pneumocystis carinii Pneumonia in Critically Ill Patients with Malignancy: A Descriptive
Study.
Zahar JR, Robin M, Azoulay E, et al.
Clin Infect Dis 2002 Oct 15;35(8):929-34
Abstract

HIV-related Pneumocystis carinii Pneumonia in Older Patients Hospitalized in the Early
HAART Era.
Kim B, Lyons TM, Parada JP, et al.
J Gen Intern Med 2001 Sep;16(9):583-589
Abstract

Acute Respiratory Failure Following HAART Introduction in Patients Treated for
Pneumocystis carinii Pneumonia.
Wislez M, Bergot E, Antoine M, et al.
Am J Respir Crit Care Med 2001 Sep 1;164(5):847-851
Abstract

Risk factors for prophylaxis failure in patients receiving aerosol pentamidine for
Pneumocystis carinii pneumonia prophylaxis.
Wei CC, Gardner S, Rachlis A, Pack LL, Chan CK.
Chest 2001 May;119(5):1427-33
Abstract

Prognostic markers of short-term mortality in AIDS-associated Pneumocystis carinii
pneumonia
Benfield TL, Helweg-Larsen J, Bang D, et al
Chest 2001 Mar;119(3):844-51
Abstract

FULL-TEXT ARTICLE
Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985
to1995: comparison of HIV-associated cases to other immunocompromised states
Mansharamani NG, Garland R, Delaney D, Koziel H.
Chest. 2000 Sep;118(3):575-7
Paper

Non-HIV-Associated Pneumocystis Pneumonia

Journal Papers, Abstracts, and Commentaries

Therapeutic Effect of Direct Hemoperfusion with a Polymyxin B-Immobilized Fiber Column in the
Treatment of HIV-Negative Severe Pneumocystis Pneumonia.
Tachikawa R, Tomii K, Murase K, et al
Respiration. 2010 Jun 9
Abstract

Fact or Fiction: Does the Non-HIV/AIDS Immunosuppressed Patient Need Pneumocystis jiroveci
Pneumonia Prophylaxis? An Updated Literature Review.
Grewal P, Brassard A.
J Cutan Med Surg. 2009 Nov-Dec;13(6):308-12
Abstract

Successful treatment of severe pneumocystis pneumonia with clindamycin-primaquine in an
HIV-negative patient.
Crisp HC, Stewart IJ, Blatz PJ, et al
South Med J. 2009 Nov;102(11):1161-3.
Abstract

Pneumocystis jirovecii pneumonia in patients with and without human immunodeficiency virus infection.
Su YS, Lu JJ, Perng CL, Chang FY.
J Microbiol Immunol Infect. 2008 Dec;41(6):478-82.
Abstract

Pneumocystis carinii pneumonia infection in a patient with known chronic
mucocutaneous candidiasis.
Ckeon DJ, White W, Sinclair D, Goldman JM.
Respirology. 2005 Jun;10(3):399-401.
Abstract

FULL-TEXT ARTICLE
Pneumocystis pneumonia: miles to go.
Masur H, Shelhamer JH. Chest. 2000
Sep;118(3):704-11
Paper

FULL-TEXT ARTICLE
Peripheral blood CD4 + T-lymphocyte counts during Pneumocystis carinii pneumonia in
immunocompromised patients without HIV infection.
Mansharamani NG, Balachandran D, Vernovsky I, et al.
Chest 2000 Sep;118(3):712-20
Paper

FULL-TEXT ARTICLE
Improvements in outcomes of acute respiratory failure for patients with human
immunodeficiency virus-related Pneumocystis carinii pneumonia.
Randall Curtis J, Yarnold PR, Schwartz DN, et al.
Am J Respir Crit Care Med 2000 Aug;162(2 Pt1):393-8
Paper

Treatment/Prevention Guidelines

United States

HIV-Associated Pneumocystis carinii Pneumonia

United States

Journal Papers, Abstracts, and Commentaries

Treating Opportunistic Infections Among HIV-Infected Adults and Adolescents:
Recommendations from CDC, the National Institutes of Health, and the HIV
Medicine Association/Infectious Diseases Society of America
MMWR Dec 17, 2004 / Vol. 53 / No. RR--1
Paper

P. Pneumonia Main Page Main New/Newsworthy Home Page

Pneumocystis jirovecii (carinii) Pneumonia
Clinical Management